sulphapyridine. No other toxic symptoms were observed.
Results
The prompt and consistent precipitation of crisis following the oral administration of sulphapyridine has been reported by many observers, and our experience is no different. This reaction occurred within eighteen to twenty-four hours in sixty-nine of the seventy-nine patients with lobar pneumonia. Of course, it is possible that the drop in temperature of some of the patients coincided with the normal crisis, but such an explanation cannot account for all the reactions, particularly in those treated very early in the disease. Many of the patients treated on the eighth to the eleventh day were acutely ill with type XIV pneumonia, in which the average duration is from eight to fourteen days.
It has been stated that, although sulphapyridine provokes a crisis, the disease runs its course, and the consolidation does not resolve sooner than it would have done if untreated. This suggestion is contrary to our experience. The x-ray shadows and the physical signs begin to clear at once just as they do after a normal crisis.
The three patients with lobar pneumonia who failed to show the typical response to sulphapyridine were all infants under 2 years of age, all severely ill. It is possible that the sustained temperature in the first one of these patients was a febrile evidence of sulphapyridine intolerance or intoxication, since this baby had other signs of reaction, namely extreme restlessness, delirium, pallor and marked anorexia. His blood sulphapyridine determination was 12 mg. per hundred cubic centimetres.
The second patient is remarkable only because he required forty-eight hours' therapy to produce a crisis. The third baby had pneumonia three times previously at Bellevue Hospital, some of these atypical pneumonia. We cannot explain his unusual reaction to sulphapyridine.
In five cases of lobar pneumonia, although the usual reaction occurred after sulphapyridine, secondary short febrile rises occurred. It has been suggested that the bacteriostatic action of sulphapyridine may produce improvement for a short time and then be followed by a relapse. There were only five patients whose temperature charts might be so interpreted. Only one of these cases clinically appeared like a pneumonia during the second temperature rise which yielded promptly to renewed treatment. The dosage of sulphapyridine was probably inadequate in case 5, but readministration of the drug was followed by prompt crisis. The other three patients had no new signs of pneumonia. One of these received no more drug, and the fever subsided just as promptly as in the cases in which it was given, so that it is not certain that any patients had true relapses. Short 
